News

Reported tuberculosis (TB) disease diagnoses in the United States fell 20% during the first year of the pandemic and remained 13% lower last year than the pre-pandemic era, latest data showed this week.  TB Trends In The U.S. On Thursday, the Centers for Disease Control and Prevention (CDC) released a media statement on the TB
0 Comments
Patients undergoing primary reverse shoulder arthroplasty (RSA) for their glenohumeral osteoarthritis (OA) had more complications of care and higher hospital costs when they also had a diagnosis of depression, new data show. The abstract was presented Thursday at the American Academy of Orthopedic Surgeons (AAOS) 2022 Annual Meeting. Researchers, led by Keith Diamond, MD, an
0 Comments
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Patients with gastrointestinal cancer face a high risk for constipation, typically greater than with other cancers. The researchers found diet and medication-related factors represented the primary risk factors for constipation in this patient
0 Comments
A small, and likely decreasing, number of healthcare providers in the United States perform abortions, and there is a risk that the count will be shrinking in the face of legislative attacks on the service, researchers have found. Until now, producing an accurate count of abortion service providers in the United States has been difficult,
0 Comments
Severe asthma treatment with the interleukin-5 antagonist mepolizumab (Nucala) reduced the need to take oral corticosteroids in patients who had depended on steroids to control symptoms, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI). In this exclusive MedPage Today video, study author Mark Liu,
0 Comments
The use of an electronic clinical decision support tool called “ePNa” reduced severity-adjusted, 30-day, all-cause mortality by 38% across 16 community hospitals in Utah compared with predeployment levels, a 3-year, pragmatic, cluster-controlled study shows. “We designed the ePNa specifically to require minimal input from the clinician so everything it does is already in the electronic medical
0 Comments
Third-party vendor physicians appear to be more much more likely than their system-employed counterparts to prescribe antibiotics during acute care telehealth visits for acute respiratory infection (ARI), according to a recent study in the Journal of Telemedicine and Telecare. As health systems expand their direct-to-consumer (DTC) virtual care, the quality of that care seems to
0 Comments
Ordering? Authorizing? Supervising? Interpreting? These are the headers that are attached to orders in our electronic medical record, which have historically let you know who ordered a test, who approved its being ordered, who was the supervising physician for the case — in the case of trainee cases — and, in the case of radiology
0 Comments
WASHINGTON – Research on standardized microbiome-based therapies designed to prevent the recurrence of Clostridioides difficile infection (CDI) is moving “with a lot of momentum,” according to one expert, and modulation of the gut microbiome may even enhance responses to immunotherapy and/or abrogate toxicity, according to another. Several products for prevention of CDI recurrence are poised
0 Comments
Immune checkpoint inhibitors (ICIs) have unquestionably revolutionized the care of patients with malignant melanoma, non-small cell lung cancer, and other types of cancer. But about 40% of patients with cancer treated with ICIs will experience immune-related dermatologic adverse events that can range from mild rashes and hair and nail changes to uncommon but life-threatening complications,
0 Comments
COVID-19 cases are rising in the United Kingdom once again, with the latest data showing a dramatic rise in transmissions in recent weeks. The surge comes two weeks after the country dropped its last remaining COVID preventive measure that forced people to self-isolate after testing positive for the novel coronavirus.  The UK has changed its
0 Comments
PHOENIX — Selinexor (Xpovio) improved outcomes when used as maintenance therapy for patients with advanced or recurrent endometrial cancer who responded to front-line chemotherapy, a researcher reported. In the placebo-controlled, phase III ENGOT-EN5/GOG-3055/SIENDO study, patients in the audited intention-to-treat population who received selinexor experienced a 30% reduction in the risk of disease progression or death
0 Comments